Managing Director, Head of European Pharmaceutical Research
Michael Leuchten is a managing director at UBS and heads the European pharmaceutical research team. The team is currently ranked runner up in the Institutional Investor survey. He is covering analyst for Roche, AstraZeneca, Bayer, Novo Nordisk, Merck KGaA, Lundbeck, Ipsen, Polyphor and Sartorius/Sartorius Stedim. Michael has been covering the sector as a sell-side analyst since 2001. Prior to joining UBS in August 2016, Michael was co-head of the European pharmaceutical team at Barclays.